A Pilot Clinical Trial of Sympathetic Blockade With Botulinum Toxin Type A to Treat Complex Regional Pain Syndrome (CRPS): a Randomized, Double-Blind, Controlled, Crossover Trial.
This study has been completed.
First Posted: March 18, 2008
Last Update Posted: January 19, 2011
Information provided by: